These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Leishmania / HIV co-infections. Desjeux P Afr Health; 1995 Nov; 18(1):20-2. PubMed ID: 12290565 [TBL] [Abstract][Full Text] [Related]
3. [Feline leishmaniasis: what's the epidemiological role of the cat?]. Mancianti F Parassitologia; 2004 Jun; 46(1-2):203-6. PubMed ID: 15305717 [TBL] [Abstract][Full Text] [Related]
4. [Interpretation of laboratory data during cryptic leishmaniasis in dog]. Gravino AE Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723 [TBL] [Abstract][Full Text] [Related]
5. [Canine leishmaniasis: evolution of the chemotherapeutic protocols]. Oliva G; Foglia Manzillo V; Pagano A Parassitologia; 2004 Jun; 46(1-2):231-4. PubMed ID: 15305724 [TBL] [Abstract][Full Text] [Related]
6. Trypanosomiasis re-emerges under cover of war. Afr Health; 1997 Sep; 19(6):3. PubMed ID: 12321240 [TBL] [Abstract][Full Text] [Related]
7. [AIDS: the children also]. Kpatinde F Jeune Afr; 1987 Oct; (1399):58-60. PubMed ID: 12341552 [TBL] [Abstract][Full Text] [Related]
8. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine. Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038 [TBL] [Abstract][Full Text] [Related]
9. New light shed on the importance and care of onchocercal skin disease. TDR News; 1998 Feb; (55):5. PubMed ID: 12348563 [TBL] [Abstract][Full Text] [Related]
10. Public / private partnership: developing an oral treatment for visceral leishmaniasis. Mattock N TDR News; 1999 Oct; (60):1-2. PubMed ID: 12295471 [TBL] [Abstract][Full Text] [Related]
11. A review of visceral leishmaniasis during the conflict in South Sudan and the consequences for East African countries. Al-Salem W; Herricks JR; Hotez PJ Parasit Vectors; 2016 Aug; 9(1):460. PubMed ID: 27549162 [TBL] [Abstract][Full Text] [Related]
12. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences. Ali A Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830 [TBL] [Abstract][Full Text] [Related]
13. The epidemic of visceral leishmaniasis in western Upper Nile, southern Sudan: course and impact from 1984 to 1994. Seaman J; Mercer AJ; Sondorp E Int J Epidemiol; 1996 Aug; 25(4):862-71. PubMed ID: 8921468 [TBL] [Abstract][Full Text] [Related]
14. AIDS lays waste to Uganda. Bond C New Afr; 1986 Jul; (226):30-1. PubMed ID: 12340745 [TBL] [Abstract][Full Text] [Related]
15. Epidemiology of the leishmaniases. Magill AJ Dermatol Clin; 1995 Jul; 13(3):505-23. PubMed ID: 7554500 [TBL] [Abstract][Full Text] [Related]
19. Situational analysis of leishmaniases research in Kenya. Tonui WK Afr J Health Sci; 2006; 13(1-2):7-21. PubMed ID: 17348738 [TBL] [Abstract][Full Text] [Related]
20. Clinical and epidemiological patterns of leishmaniasis in Africa. Cahill KM Trop Geogr Med; 1968 Jun; 20(2):109-17. PubMed ID: 4871799 [No Abstract] [Full Text] [Related] [Next] [New Search]